Clomifen-ratiopharm® 50 mg

Clomid is an anti-estrogenic drug. It belongs to the class of SERMs, i.e. selective estrogen receptor modulators. This means that the molecule of such a drug successfully attaches to estrogen receptors, but activates them in some tissues and blocks them in others. Clomid blocks estrogen receptors mainly in the hypothalamus and pituitary gland. In other tissues, however, it tends to activate these receptors.

On the one hand, such selectivity is for the good: clomid is able to activate estrogen receptors in cartilage and bone tissue, which means that the risk of osteoporosis and joint damage that usually accompanies the use of anti-estrogenic drugs is minimal in its case. In addition, the increase in estradiol levels always accompanying the use of SERMs, in the case of clomid can not be called so significant. But, on the other hand, clomid does not particularly prevent water retention in the body, so there is absolutely no point in using it at the stage of preparation for competitions.

The medical purpose of clomid is to stimulate ovulation in women. It occurs by blocking estrogen receptors in the hypothalamus and ovaries, resulting in stimulation of secretion of luteinising (LH) and follicle-stimulating (FSH) hormones, as well as prolactin.

But exactly the same is true for the male body, it is very often used in medical practice to treat too low testosterone levels in the stronger sex, as well as related infertility.